WaljiRBoonHBarnesJ. Consumers of natural health products: natural-born pharmacovigilantes?BMC Complement Altern Med2010;10(8). Available: www.biomedcentral.com/1472-6882/10/8 (accessed Feb. 23, 2012).
4.
BarnesJ. Pharmacovigilance of herbal medicines. Drug Saf2003;26:829-51.
5.
ShawDLaddsGDuezP. Pharmacovigilance of herbal medicine. J Ethnopharmacol2012;140:513-8.
6.
RaynorDKDickinsonRKnappP. Buyer beware? Does the information provided with herbal products available over the counter enable safe use?BMC Med2011;9:94.
7.
TeschkeR. Kava hepatotoxicity—a clinical review. Ann Hepatol2010;9:251-65.
8.
RahimiRAbdollahiM. An update on the ability of St. John’s wort to affect the metabolism of other drugs. Expert Opin Drug Metab Toxicol2012;8:691-708.
9.
VohraSCvijovicKBoonH. Study of natural health product adverse reactions (SONAR): active surveillance of adverse events following concurrent natural health product and prescription drug use in community pharmacies. PLoS One2012;7(9):e45196.
BusseJWHeatonGWuP. Disclosure of natural product use to primary care physicians: a cross-sectional survey of naturopathic clinic attendees. Mayo Clin Proc2005;80:616-23.
12.
VerhoefMJBoonHSPageSA. Talking to cancer patients about complementary therapies: is it the physician’s responsibility?Curr Oncol2008;15(suppl 2):s88-s93.
13.
ChenXWSneedKBPanSY. Herb-drug interactions and mechanistic and clinical considerations. Curr Drug Metab2012;13:640-51.
14.
KellyJPKaufmanDWKelleyK. Recent trends in use of herbal and other natural products. Arch Intern Med2005;165:281-6.
15.
BergerE. Berger Population Health Monitor: Pharmacy medication and consumer health products report. Survey 2. Toronto (ON): The Hay Health Care Consulting Group; 2002.
16.
BoullataJ. Natural health product interactions with medication. Nutr Clin Pract2005;20:33-51.